Transcriptomes of human prostate cells

BackgroundThe gene expression profiles of most human tissues have been studied by determining the transcriptome of whole tissue homogenates. Due to the solid composition of tissues it is difficult to study the transcriptomes of individual cell types that compose a tissue. To overcome the problem of heterogeneity we have developed a method to isolate individual cell types from whole tissue that are a source of RNA suitable for transcriptome profiling.ResultsUsing monoclonal antibodies specific for basal (integrin β4), luminal secretory (dipeptidyl peptidase IV), stromal fibromuscular (integrin α 1), and endothelial (PECAM-1) cells, respectively, we separated the cell types of the prostate with magnetic cell sorting (MACS). Gene expression of MACS-sorted cell populations was assessed with Affymetrix GeneChips. Analysis of the data provided insight into gene expression patterns at the level of individual cell populations in the prostate.ConclusionIn this study, we have determined the transcriptome profile of a solid tissue at the level of individual cell types. Our data will be useful for studying prostate development and cancer progression in the context of single cell populations within the organ.

[1]  J. Foidart,et al.  Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. , 1997, The American journal of pathology.

[2]  K. Huppi,et al.  Molecular profiling of prostate cancer , 2004, Current urology reports.

[3]  S. Kajigaya,et al.  Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. , 2004, Experimental hematology.

[4]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[5]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  V. Reuter,et al.  Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue , 1997, The Prostate.

[7]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[8]  J. Reis-Filho,et al.  Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray , 2003, Virchows Archiv.

[9]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[10]  P. Nelson,et al.  Predicting prostate cancer behavior using transcript profiles. , 2004, The Journal of urology.

[11]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[12]  D. Danielpour.  Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. , 2005, European journal of cancer.

[13]  J. Trent,et al.  Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis , 2002, The Prostate.

[14]  Roger E Bumgarner,et al.  Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium. , 2001, Cancer research.

[15]  L. True,et al.  Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. , 2004, The American journal of pathology.

[16]  Lawrence D True,et al.  Characterization of prostate cell types by CD cell surface molecules. , 2002, The American journal of pathology.

[17]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.

[18]  D. Jeulin,et al.  Computer‐based detection of neonatal changes to branching morphogenesis reveals different mechanisms of and predicts prostate enlargement in mice haplo‐insufficient for bone morphogenetic protein 4 , 2005, The Journal of pathology.

[19]  D. Födinger,et al.  High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease. , 1995, The Journal of urology.

[20]  M. Albrecht,et al.  Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells , 2004, The Prostate.

[21]  G van den Engh,et al.  Cell-cell interaction in prostate gene regulation and cytodifferentiation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Hollywood,et al.  Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease. , 2004, Endocrine-related cancer.

[23]  R. Hubert,et al.  Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. , 2001, Cancer research.

[24]  Debashis Ghosh,et al.  alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.

[25]  Deborah Schrag,et al.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.

[26]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[27]  R. Nagle,et al.  Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma. , 1997, The American journal of pathology.

[28]  R. Benezra,et al.  Id proteins in development, cell cycle and cancer. , 2003, Trends in cell biology.

[29]  A. Nordheim,et al.  Id Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells* , 1999, The Journal of Biological Chemistry.

[30]  Nan Wang,et al.  Getting the right cells to the array: Gene expression microarray analysis of cell mixtures and sorted cells , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[31]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[32]  J. Clemens,et al.  Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. , 2001, Developmental biology.

[33]  R L Vessella,et al.  Bone morphogenetic protein signaling in prostate cancer cell lines , 2004, Journal of cellular biochemistry.

[34]  J. Reems,et al.  Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. , 2004, Experimental hematology.